NuWave Investment Management LLC purchased a new stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,044 shares of the pharmacy operator’s stock, valued at approximately $221,000.
Other hedge funds have also recently added to or reduced their stakes in the company. Private Vista LLC raised its position in shares of Walgreens Boots Alliance by 6,403.7% during the second quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock valued at $140,000 after buying an additional 574,218 shares during the last quarter. Wayne Hummer Investments L.L.C. raised its position in shares of Walgreens Boots Alliance by 23.3% during the second quarter. Wayne Hummer Investments L.L.C. now owns 14,197 shares of the pharmacy operator’s stock valued at $1,112,000 after buying an additional 2,682 shares during the last quarter. Peddock Capital Advisors LLC raised its position in shares of Walgreens Boots Alliance by 8.7% during the second quarter. Peddock Capital Advisors LLC now owns 4,577 shares of the pharmacy operator’s stock valued at $358,000 after buying an additional 366 shares during the last quarter. Pax World Management LLC raised its position in Walgreens Boots Alliance by 10.8% in the second quarter. Pax World Management LLC now owns 7,200 shares of the pharmacy operator’s stock worth $564,000 after purchasing an additional 700 shares in the last quarter. Finally, Boston Private Wealth LLC raised its position in Walgreens Boots Alliance by 1.8% in the second quarter. Boston Private Wealth LLC now owns 176,324 shares of the pharmacy operator’s stock worth $13,808,000 after purchasing an additional 3,172 shares in the last quarter. Institutional investors own 61.57% of the company’s stock.
In other news, insider Stefano Pessina acquired 98,858 shares of the company’s stock in a transaction dated Monday, January 15th. The stock was bought at an average price of $76.07 per share, with a total value of $7,520,128.06. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 14.80% of the company’s stock.
Shares of Walgreens Boots Alliance Inc (WBA) opened at $68.49 on Thursday. The firm has a market cap of $67,850.00, a P/E ratio of 18.92, a PEG ratio of 1.16 and a beta of 1.18. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96. Walgreens Boots Alliance Inc has a fifty-two week low of $63.82 and a fifty-two week high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.01. The company had revenue of $30.74 billion during the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The company’s revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the business posted $1.10 earnings per share. equities research analysts forecast that Walgreens Boots Alliance Inc will post 5.71 EPS for the current year.
Walgreens Boots Alliance announced that its board has approved a stock buyback plan on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to repurchase shares of its stock through open market purchases. Shares buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 12th. Stockholders of record on Thursday, February 15th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.34%. The ex-dividend date is Wednesday, February 14th. Walgreens Boots Alliance’s payout ratio is 44.20%.
Several research analysts recently issued reports on the stock. Needham & Company LLC reissued a “buy” rating and issued a $88.00 price target (up previously from $86.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, January 10th. BidaskClub raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, January 10th. Zacks Investment Research raised shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $76.00 price target for the company in a research report on Wednesday. Loop Capital set a $90.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Thursday, October 26th. Finally, ValuEngine lowered shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Ten investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Buy” and a consensus price target of $85.05.
WARNING: This article was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://ledgergazette.com/2018/02/15/nuwave-investment-management-llc-takes-position-in-walgreens-boots-alliance-inc-wba.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.